CLINICAL PROFILE AND CORRELATION OF SERUM BNP LEVEL AT ADMISSION WITH ICU STAY DURATION IN PATIENTS OF ACUTE DECOMPENSATED HEART FAILURE

Dr Sagar Desai, Dr Ayush M Patel

Abstract


BACKGROUNDS:

Serum BNP levels have been established for diagnosis of HF in proportion to severity of symptoms, degree of LV dysfunction with other comorbidity and predict morbidity and mortality in HF pts.

Methods:

A Case series  descriptive study of 50 patients admitted in ICU of HSK Hospital, Bagalkot in duration of 3 months of study period with HF      (according to symptoms and LV dysfunction) and perform spot test of serum BNP level(reference value >100pg/ml) and correlate with pts ICU stay duration.

Results:

Study comprised of 50 HF pts. In this study mean age of 63 yr pts and their association distribution with BNP level was 1100 pg/ml and 4 days of mean ICU stay by using Pearson Chi-Square test (X2-0.996b). High level of BNP with other comorbities also prolong the duration of ICU stay.

  • Conclusion:  This Study shows that in patients with heart failure, raise BNP level is associated with long ICU stay in hospital. So, it can use as predictor for in hospital treatment. Further this Study shows possibility of associated complications with various comorbidities in heart failure
  • patients, who had raised BNP levels. So, it can use as a prognostic indicator.

 

Keywords


HF-Heart Failure, BNP-Brain Natriuretic peptide, HTN-Hypertension DM-Diabetes Mellitus, IHD-Ischemic Heart Disease

Full Text:

PDF

References


Nieminen MS, Bohm M, Cowie MR, et al: Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 2005; 26:384–416

Nohria A, Mielniczuk LM, Stevenson LW: Evaluation and monitoring of patients with acute heart failure syndromes. Am J Cardiol 2005; 96:32G–40G

Sudoh T, Kangawa K, Minamino N, et al: A new natriuretic peptide in porcine brain. Nature 1988; 332:78–81

Mukoyama M, Nakao K, Hosoda K, et al: Brain natriuretic peptide as a novel cardiac hormone in humans: Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87:1402–1412 5. RuskoahoH:Cardiachormonesasdiagnostic tools in heart failure. Endocr Rev 2003; 24: 341–356

de Lemos JA, McGuire DK, Drazner MH: Btype natriuretic peptide in cardiovascular disease. Lancet 2003; 362:316–322

Yandle TG, Richards AM, Gilbert A, et al: Assay of brain natriuretic peptide (BNP) in human plasma: Evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab 1993; 76:832–838

Hawkridge AM, Heublein DM, Bergen HR III, et al: Quantitative mass spectral evidence for the absence of circulating brain natriuretic peptide (BNP-32) in severe human heart failure. Proc Natl Acad SciUSA2005; 102: 17442–17447

Kinnunen P, Vuolteenaho O, Ruskoaho H: Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: Effect of stretching. Endocrinology 1993; 132:1961–1970

Espiner EA, Richards AM, Yandle TG, et al: Natriuretic hormones. Endocrinol Metab Clin North Am 1995; 24:481–509


Refbacks

  • There are currently no refbacks.